Self-Regulation as a Collective Blocking Strategy PhRMA’s DTC Guiding Principles Taken to Task
PhRMA first issued its Guiding Principles for Direct to Consumer (DTC) Advertisements in August 2005, and revised them in March 2009. The principles are only “guidelines” — not rules — and signatory companies agree to “voluntarily” follow them.
Has the drug industry systematically violated PhRMA’s DTC Principles? Is pharma self-regulation a deception meant to deflect criticism and block new FDA regulations? The answer is “yes,” according to a study recently published in the Journal of Health Politics, Policy and Law. The study authors provide convincing evidence, which is summarized in this article.
- PhRMA’s Lax Accountability Regime
- The Appropriate Audience …Not!
- Deflecting Regulations
- Collective Blocking Strategy
- Enactment of New Laws Were Blocked
- Policy Recommendations
Download the full text PDF file here:
Issue: Vol. 12, No. 2: 20 February 2013
- Direct-to-Consumer (DTC) Advertising & Marketing
- Regulatory Compliance
- Strategic Marketing & Planning